BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19580622)

  • 1. Hypercalcaemia caused by a carcinoid tumour.
    Brzozowska MM; Wolmarans L; Conaglen JV
    Intern Med J; 2009 Jun; 39(6):415-8. PubMed ID: 19580622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intractable hypercalcaemia due to parathyroid hormone-related peptide secretion by a carcinoid tumour.
    Mantzoros CS; Suva LJ; Moses AC; Spark R
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):373-5. PubMed ID: 9156050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin receptor expression in a parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour causing severe hypercalcaemia.
    Müssig K; Petersenn S; Wehrmann M; Horger M; Vierling P; Häring HU; Gallwitz B
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):719-23. PubMed ID: 17625444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumours: case series and literature review.
    Srirajaskanthan R; McStay M; Toumpanakis C; Meyer T; Caplin ME
    Neuroendocrinology; 2009; 89(1):48-55. PubMed ID: 18679021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic neuroendocrine tumor with extensive vascularisation and parathyroid hormone-related protein (PTHrP)--associated hypercalcemia of malignancy.
    Clemens P; Gregor M; Lamberts R
    Exp Clin Endocrinol Diabetes; 2001; 109(7):378-85. PubMed ID: 11573150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of gastrointestinal neuroendocrine tumors with the somatostatin analog octreotide (Sandostatin)].
    Stöckmann F; Creutzfeldt W
    Z Gastroenterol; 1988 Oct; 26(10):665-75. PubMed ID: 2849248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercalcaemia in a patient with fatal adenosquamous carcinoma of the colon.
    Links M; Ho H; Clingan P; Diamond T
    Med J Aust; 1994 Mar; 160(5):286-7. PubMed ID: 8107631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intractable hypercalcemia due to a metastatic carcinoid secreting parathyroid hormone-related peptide and interleukin-6: response to octreotide.
    Barhoum M; Hutchins L; Fonseca VA
    Am J Med Sci; 1999 Sep; 318(3):203-5. PubMed ID: 10487414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acromegaly caused by a growth hormone-releasing hormone secreting carcinoid tumour of the lung: the effect of octreotide treatment.
    de Jager CM; de Heide LJ; van den Berg G; Wolthuis A; van Schelven WD
    Neth J Med; 2007; 65(7):263-6. PubMed ID: 17656813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromogranin A as a determinant of midgut carcinoid tumour volume.
    Kölby L; Bernhardt P; Swärd C; Johanson V; Ahlman H; Forssell-Aronsson E; Stridsberg M; Wängberg B; Nilsson O
    Regul Pept; 2004 Aug; 120(1-3):269-73. PubMed ID: 15177946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid hormone-related protein (PTHrP) gene expression in solid tumours associated with normocalcaemia and hypercalcaemia.
    Dunne FP; Lee S; Ratcliffe WA; Hutchesson AC; Bundred NJ; Heath DA
    J Pathol; 1993 Nov; 171(3):215-21. PubMed ID: 8277370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic neuroendocrine tumor associated with humoral hypercalcemia of malignancy and carcinoid tumor: a case report and review of the literature.
    Shah RH; Martinez D
    Pancreas; 2013 Apr; 42(3):549-51. PubMed ID: 23211368
    [No Abstract]   [Full Text] [Related]  

  • 13. Parathyroid hormone-related protein, bone metastases and hypercalcaemia of malignancy.
    Bundred NJ; Walls J; Ratcliffe WA
    Ann R Coll Surg Engl; 1996 Jul; 78(4):354-8. PubMed ID: 8712650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oesophageal carcinoma with humoral hypercalcaemia of malignancy and leucocytosis.
    Watanabe HA; Matsushita H; Matsui H; Ishida A; Taguchi S; Sata H; Amano N
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):497-9. PubMed ID: 8804880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung tumours immunoreactive for parathyroid hormone related peptide: analysis of serum calcium levels and tumour type.
    Davidson LA; Black M; Carey FA; Logue F; McNicol AM
    J Pathol; 1996 Apr; 178(4):398-401. PubMed ID: 8691317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of carcinoid tumor with a long-acting somatostatin analog].
    Werling K; Lengyel G; Fehér E; Jakab Z; Besznyák I; Feher J
    Orv Hetil; 1993 Feb; 134(6):301-5. PubMed ID: 8430017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Paraneoplastic hypercalcaemia in a case of carcinoma of the bladder. Demonstration in the tumour of a substance with parathormone activity (author's transl)].
    Becq-Giraudon B; Marechaud R; Pouget Abadie JF; Sudre Y
    Nouv Presse Med; 1979 Apr; 8(16):1333-5. PubMed ID: 482102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoid tumor and intravenous octreotide infusion during labor and delivery.
    Le BT; Bharadwaj S; Malinow AM
    Int J Obstet Anesth; 2009 Apr; 18(2):182-5. PubMed ID: 19200714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parathyroid hormone-related protein in pancreatic exocrine cancer associated with hypercalcaemia.
    Bandyopadhyay P; Baksi S; Bandyopadhyay D; Patel CU
    Int J Clin Pract; 2003 Mar; 57(2):140-2. PubMed ID: 12661799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid hormone-related protein-secreting uterine endometrioid adenocarcinoma.
    Kinugasa Y; Morishige K; Kamiura S; Tsukamoto Y; Saji F
    Jpn J Clin Oncol; 2006 Feb; 36(2):113-5. PubMed ID: 16418186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.